The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

The epidermal growth factor receptor (EGFR) is a therapeutic target in head and neck squamous cell carcinoma (HNSCC). Resistance to EGFR-targeted therapies, such as cetuximab, poses a challenging problem. This study aims to characterize acquired cetuximab resistance mechanisms in HNSCC cell lines by...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaryouh, Hannah, De Pauw, Ines, Baysal, Hasan, Pauwels, Patrick, Peeters, Marc, Vermorken, Jan Baptist, Lardon, Filip, Wouters, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462273/
https://www.ncbi.nlm.nih.gov/pubmed/34568028
http://dx.doi.org/10.3389/fonc.2021.697967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462273/
https://www.ncbi.nlm.nih.gov/pubmed/34568028
http://dx.doi.org/10.3389/fonc.2021.697967

Ejemplares similares